David C. Musch

David C. Musch

Auto-generated profile, based on publicly available information

David C. Musch

Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in The Lancet Global Health
Verified
Journal Article
Open access
SFSeth R Flaxman
Seth R Flaxman
RBRupert R A Bourne
Rupert R A Bourne
SRSerge Resnikoff
Serge Resnikoff
PAPeter Ackland
Peter Ackland
TBTasanee Braithwaite
Tasanee Braithwaite
YZYingfeng Zheng
Yingfeng Zheng
Contemporary data for causes of vision impairment and blindness form an important basis of recommendations in public health policies. Refreshment of the Global Vision Database with recently published data sources permitted modelling of cause of vision loss data from 1990 to 2015, further disaggregation by cause, and forecasts to 2020. In this systematic review and meta-analysis, we analysed published and unpublished population-based data for the causes of vision impairment and blindness from 1980 to 2014. We identified population-based studies published before July 8, 2014, by searching online databases with no language restrictions (MEDLINE from Jan 1, 1946, and Embase from Jan 1, 1974, and the WHO Library Database). We fitted a series of regression models to estimate the proportion of moderate or severe vision impairment (defined as presenting visual acuity of 14% of blindness) as causes in the high-income subregions. Blindness and vision impairment at all ages in 2015 due to diabetic retinopathy (odds ratio 2·52 [1·48-3·73]) and cataract (1·21 [1·17-1·25]) were more common among women than among men, whereas blindness and vision impairment due to glaucoma (0·71 [0·57-0·86]) and corneal opacity (0·54 [0·43-0·66]) were more common among men than among women, with no sex difference related to age-related macular degeneration (0·91 [0·70-1·14]). The number of people affected by the common causes of vision loss has increased substantially as the population increases and ages. Preventable vision loss due to cataract (reversible with surgery) and refractive error (reversible with spectacle correction) continue to cause most cases of blindness and moderate or severe vision impairment in adults aged 50 years and older. A large scale-up of eye care provision to cope with the increasing numbers is needed to address avoidable vision loss. Brien Holden Vision Institute.

1 September 2017 in The Lancet Global Health
Verified
Journal Article
Open access
RBRupert R A Bourne
Rupert R A Bourne
SFSeth R Flaxman
Seth R Flaxman
TBTasanee Braithwaite
Tasanee Braithwaite
ADAditi Das
Aditi Das
JJJost B Jonas
Jost B Jonas
YZYingfeng Zheng
Yingfeng Zheng
Global and regional prevalence estimates for blindness and vision impairment are important for the development of public health policies. We aimed to provide global estimates, trends, and projections of global blindness and vision impairment. We did a systematic review and meta-analysis of population-based datasets relevant to global vision impairment and blindness that were published between 1980 and 2015. We fitted hierarchical models to estimate the prevalence (by age, country, and sex), in 2015, of mild visual impairment (presenting visual acuity worse than 6/12 to 6/18 inclusive), moderate to severe visual impairment (presenting visual acuity worse than 6/18 to 3/60 inclusive), blindness (presenting visual acuity worse than 3/60), and functional presbyopia (defined as presenting near vision worse than N6 or N8 at 40 cm when best-corrected distance visual acuity was better than 6/12). Globally, of the 7·33 billion people alive in 2015, an estimated 36·0 million (80% uncertainty interval [UI] 12·9-65·4) were blind (crude prevalence 0·48%; 80% UI 0·17-0·87; 56% female), 216·6 million (80% UI 98·5-359·1) people had moderate to severe visual impairment (2·95%, 80% UI 1·34-4·89; 55% female), and 188·5 million (80% UI 64·5-350·2) had mild visual impairment (2·57%, 80% UI 0·88-4·77; 54% female). Functional presbyopia affected an estimated 1094·7 million (80% UI 581·1-1686·5) people aged 35 years and older, with 666·7 million (80% UI 364·9-997·6) being aged 50 years or older. The estimated number of blind people increased by 17·6%, from 30·6 million (80% UI 9·9-57·3) in 1990 to 36·0 million (80% UI 12·9-65·4) in 2015. This change was attributable to three factors, namely an increase because of population growth (38·4%), population ageing after accounting for population growth (34·6%), and reduction in age-specific prevalence (-36·7%). The number of people with moderate and severe visual impairment also increased, from 159·9 million (80% UI 68·3-270·0) in 1990 to 216·6 million (80% UI 98·5-359·1) in 2015. There is an ongoing reduction in the age-standardised prevalence of blindness and visual impairment, yet the growth and ageing of the world's population is causing a substantial increase in number of people affected. These observations, plus a very large contribution from uncorrected presbyopia, highlight the need to scale up vision impairment alleviation efforts at all levels. Brien Holden Vision Institute.

1 September 2009 in Ophthalmology
Verified
Journal Article
Closed access
WLW. Barry Lee
W. Barry Lee
DJDeborah S. Jacobs
Deborah S. Jacobs
DMDavid C. Musch
David C. Musch
SKStephen C. Kaufman
Stephen C. Kaufman
WRWilliam J. Reinhart
William J. Reinhart
RSRoni M. Shtein
Roni M. Shtein

1 January 2011 in Ophthalmology
Verified
Journal Article
Closed access
WRWilliam J. Reinhart
William J. Reinhart
DMDavid C. Musch
David C. Musch
DJDeborah S. Jacobs
Deborah S. Jacobs
WLW. Barry Lee
W. Barry Lee
SKStephen C. Kaufman
Stephen C. Kaufman
RSRoni M. Shtein
Roni M. Shtein

1 February 2009 in Ophthalmology
Verified
Journal Article
Closed access
DMDavid C. Musch
David C. Musch
BGBrenda W. Gillespie
Brenda W. Gillespie
PLPaul R. Lichter
Paul R. Lichter
LNLeslie M. Niziol
Leslie M. Niziol
NJNancy K. Janz
Nancy K. Janz

1 March 1992 in Ophthalmology
Verified
Journal Article
Closed access
GSGregory L. Skuta
Gregory L. Skuta
CBCharles C. Beeson
Charles C. Beeson
EHEve J. Higginbotham
Eve J. Higginbotham
PLPaul R. Lichter
Paul R. Lichter
DMDavid C. Musch
David C. Musch
FFFrancis Y. Falck
Francis Y. Falck